secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alkermes plc. (ALKS)
CIK:        0001520262
Form:       8-K
Filed at:   2021-11-19T23:59:59+00:00
Accession:  0001564590-21-057694
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alkermes appoints Dr. Cato T. Laurencin to Board under Sarissa Capital agreement
--------------------------------------------------------------------------------

- Dr. Cato T. Laurencin appointed as Class II director effective Nov 18, 2021; term expires at 2022 AGM.
- Sarissa Capital exercised its right to designate a director per the April 2021 agreement.
- Laurencin is a University of Connecticut professor specializing in regenerative engineering and health disparities.
- He will receive standard director compensation (equity grant and cash retainer) in December 2021.
- Board expanded to 12 directors; this is the sixth new independent director since 2019.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520262/000156459021057694/0001564590-21-057694-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520262/000156459021057694/alks-8k_20211118.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-057694

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer